TherapeuticsmdTXMD
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 46 institutions reported holding Therapeuticsmd Inc. (TXMD) in their 13F filings, up 4 from Q2 2025. 7 opened new positions and 3 sold out. The largest holders were Rubric Capital Management LP ($1.3M), Clearline Capital LP ($683K) and Vanguard Group Inc. ($399K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Therapeuticsmd Inc.
- CUSIP
- 88338N206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $36K |
| Exits | 3 | $617 |
All 13F filers, Q2 2025 → Q3 2025: 56,548 shares bought and 8,872 shares sold, net +47,676 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 46 holders
| Rubric Capital Management LP | 0.02% | No change | 1,192,191 | $1.3M |
| Clearline Capital LP | 0.06% | No change | 635,222 | $683K |
| Vanguard Group Inc. | 0.00% | Reduce -0.6% | 376,828 | $399K |
| Tejara Capital Ltd | 0.20% | Reduce -0.0% | 344,203 | $370K |
| ADAR1 Capital Management, LLC | 0.02% | No change | 209,210 | $225K |
| Morgan Stanley | 0.00% | Reduce -0.5% | 130,572 | $140K |
| BlackRock, Inc. | 0.00% | No change | 116,132 | $125K |
| Geode Capital Management, LLC | 0.00% | No change | 109,083 | $116K |
| Renaissance Technologies | 0.00% | Add +138.3% | 35,500 | $38K |
| Citadel Advisors | 0.00% | New | 34,273 | $36K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 34,000 | $36K |
| State Street Corp. | 0.00% | No change | 30,100 | $32K |
| Northern Trust Corp. | 0.00% | No change | 16,457 | $18K |
| J. Goldman & Co LP | 0.00% | No change | 13,562 | $15K |
| Two Sigma Securities, LLC | 0.00% | Add +14.7% | 11,967 | $13K |
| FMR LLC | 0.00% | No change | 8,289 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -5.2% | 2,733 | $3K |
| Osaic Holdings, Inc. | 0.00% | Add +4.2% | 897 | $972 |
| National Bank of Canada | 0.00% | Reduce -5.6% | 670 | $710 |
| UBS Group AG | 0.00% | Reduce -92.0% | 362 | $390 |
| JPMorgan Chase & Co. | 0.00% | No change | 293 | $310 |
| SBI Securities Co., Ltd. | 0.00% | No change | 255 | $274 |
| US Bancorp \de | 0.00% | No change | 246 | $264 |
| BNP Paribas Financial Markets | 0.00% | No change | 226 | $243 |
| Huntington National Bank | 0.00% | No change | 120 | $129 |
| Bank of America Corp. | 0.00% | Reduce -79.6% | 106 | $114 |
| Barclays PLC | 0.00% | New | 44 | $47 |
| Activest Wealth Management | 0.00% | No change | 40 | $43 |
| Wells Fargo & Company | 0.00% | Reduce -35.1% | 37 | $40 |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -2.8% | 35 | $38 |
| Farther Finance Advisors, LLC | 0.00% | No change | 30 | $32 |
| Wealth Watch Advisors, INC | 0.00% | New | 22 | $24 |
| IFP Advisors, Inc | 0.00% | No change | 21 | $23 |
| Provenance Wealth Advisors, LLC | 0.00% | No change | 20 | $22 |
| Advisory Services Network, LLC | 0.00% | New | 14 | $15 |
| Truvestments Capital LLC | 0.00% | No change | 10 | $11 |
| Harbour Investments, Inc. | 0.00% | No change | 8 | $9 |
| Assetmark, Inc. | 0.00% | No change | 4 | $4 |
| Smallwood Wealth Investment Management, LLC | 0.00% | No change | 2 | $2 |
| Citigroup Inc. | 0.00% | Reduce -99.5% | 1 | $1 |
| NewEdge Advisors, LLC | 0.00% | No change | 1 | $1 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 1 | $1 |
| Strategic Advocates LLC | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -11.5% | 154 | $0 |
| Cwm, LLC | 0.00% | New | 20 | $0 |
| Banque Cantonale Vaudoise | 0.00% | New | 7 | $0 |
"% of holder's portfolio" is TXMD's weight in each manager's 13F, not the share of Therapeuticsmd Inc. the manager owns.